Ultraprocessed Foods in Colombia

The study seeks to examine how characters on packaging and warning labels affect purchase intentions and risk perception among children aged 12 to 17 in Colombia and, examine whether characters' presence weakens or reduces the perceived message effectiveness of the warning labels' impact. This will be a 2x2 between-subjects experiment manipulating presence or absence of characters and presence or absence of warning labels. Participants will be randomly assigned to 1 of 4 conditions in an online survey programmed in Qualtrics.

Study Overview

Detailed Description

This study will employ a 2x2 between-subjects experimental design to investigate the independent and combined effects of characters and front-of-package warning labels on children's risk perceptions, purchase intentions and perceived message effectiveness regarding ultra-processed foods.

After parents or legal guardians provide informed consent and the children assent to participate, the survey platform (Qualtrics) will randomly assign each child to one of four experimental conditions:

  1. Warning label + Character
  2. Warning label only
  3. Barcode control label + Character
  4. Barcode control label only

Participants will complete the study online through a self-administered survey programmed in Qualtrics. This survey has a duration of approximately 15 minutes. Each child will be exposed to three fictional ultra-processed food products (cookies package, juice bottle, and chip bag), displayed in random order. The stimuli were developed to resemble common products in Colombia but without using real brands to avoid brand loyalty bias. Each product will be displayed with a label consistent with the child's assigned experimental condition.

Children will respond to a series of questions for each product individually. These questions will assess:

  • Risk perception
  • Purchase intention
  • Perceived message effectiveness

Study Type

Interventional

Enrollment (Estimated)

1960

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Maria Parra-Murillo
  • Phone Number: 9843220948
  • Email: mparram@unc.edu

Study Locations

      • Bogotá, Colombia
        • Online panel
        • Contact:
        • Principal Investigator:
          • Luis Fernando Gómez Guitierrez, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children and adolescents between 12 and 17 years old
  • Colombian residents

Exclusion Criteria:

  • Children with legal blindness, partial blindness, or total blindness, since the study involves viewing images and reading questions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Warning label + Character
Participants will view images of three products containing octagonal warning labels.
Participants will view images of three products containing characters.
Experimental: Barcode control label + Character
Participants will view images of three products containing characters.
Participants will view images of three products containing Barcode control label.
Experimental: Warning label only
Participants will view images of three products containing octagonal warning labels.
Participants will view images of three products without characters.
Other: Barcode control label only
Participants will view images of three products containing Barcode control label.
Participants will view images of three products without characters.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Purchase intention
Time Frame: During ~15 minute online survey
Purchase intention will be assessed using 1 item: "How likely are you to consume this product?" Responses will be recorded on a 5-point Likert-style scale ranging from 1 ("Not at all likely") to 5 ("Very likely"). Because this is a single-item measure, the total score ranges from 1 to 5. Higher scores indicate greater purchase intention, whereas lower scores indicate lower purchase intention.
During ~15 minute online survey
Risk perception
Time Frame: During ~15 minute online survey
Risk perception will be assessed using 1 item: "How healthy do you think this product is?" Responses will be recorded on a 5-point Likert-style scale ranging from 1 ("Not healthy at all") to 5 ("Very healthy"). Because this is a single-item measure, the total score ranges from 1 to 5. Higher scores indicate that the product is perceived as healthier (i.e., lower perceived risk), whereas lower scores indicate that the product is perceived as less healthy (i.e., higher perceived risk).
During ~15 minute online survey

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Message Effectiveness
Time Frame: During ~15 minute online survey

Perceived message effectiveness will be assessed using 3 items, each measured on a 5-point Likert-style scale (1-5):

"How much does this label make you worry about what consuming this product will do to you?" (1 = Not at all worried; 5 = Extremely worried) "How much does this label make you think consuming this product is a bad idea?" (1 = Makes me think it's a very good idea to consume it; 5 = Makes me think it's a very bad idea to consume it) "How much does this label discourage you from consuming this product?"

(1 = Doesn't discourage me at all; 5 = Completely discourages me) For each product evaluated, a perceived message effectiveness score will be calculated as the mean of the 3 items, resulting in a score ranging from 1 to 5. Higher scores indicate greater perceived message effectiveness, whereas lower scores indicate lower perceived message effectiveness.

During ~15 minute online survey

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria Parra-Murillo, University of North Carolina, Chapel Hill
  • Study Director: Marissa Hall, PhD, University of North Carolina, Chapel Hill

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

April 7, 2026

First Submitted That Met QC Criteria

April 7, 2026

First Posted (Actual)

April 14, 2026

Study Record Updates

Last Update Posted (Actual)

April 14, 2026

Last Update Submitted That Met QC Criteria

April 7, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Warning label

Subscribe